Mechanisms of Severe Mortality-Associated Bacterial Co-infections Following Influenza Virus Infection

被引:80
|
作者
Jia, Leili [1 ]
Xie, Jing [1 ]
Zhao, Jiangyun [1 ]
Cao, Dekang [2 ]
Liang, Yuan [1 ]
Hou, Xuexin [3 ]
Wang, Ligui [1 ]
Li, Zhenjun [3 ]
机构
[1] Chinese Peoples Liberat Army, Inst Dis Control & Prevent, Beijing, Peoples R China
[2] Chinese Peoples Armed Police Forces, Ctr Dis Control & Prevent, Beijing, Peoples R China
[3] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
co-infection; influenza; bacteria; resumption of function; tolerance; mortality; RESPIRATORY-TRACT INFECTION; ACTIVATING-FACTOR RECEPTOR; STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; A VIRUS; I INTERFERONS; PNEUMOCOCCAL INFECTION; MENINGOCOCCAL DISEASE; ALVEOLAR MACROPHAGES; PANDEMIC INFLUENZA;
D O I
10.3389/fcimb.2017.00338
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Influenza virus infection remains one of the largest disease burdens on humans. Influenza-associated bacterial co-infections contribute to severe disease and mortality during pandemic and seasonal influenza episodes. The mechanisms of severe morbidity following influenza bacteria co-infections mainly include failure of an antibacterial immune response and pathogen synergy. Moreover, failure to resume function and tolerance might be one of the main reasons for excessive mortality. In this review, recent advances in the study of mechanisms of severe disease, caused by bacterial co-infections following influenza virus pathogenesis, are summarized. Therefore, understanding the synergy between viruses and bacteria will facilitate the design of novel therapeutic approaches to prevent mortality associated with bacterial co-infections.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality
    Beumer, M. C.
    Koch, R. M.
    van Beuningen, D.
    OudeLashof, A. M.
    van de Veerdonk, F. L.
    Kolwijck, E.
    van der Hoeven, J. G.
    Bergmans, D. C.
    Hoedemaekers, C. W. E.
    JOURNAL OF CRITICAL CARE, 2019, 50 : 59 - 65
  • [2] The impacts of bacterial co-infections and secondary bacterial infections on patients with severe influenza pneumonitis admitted to the intensive care units
    Lee, Wei-Chun
    Ho, Meng -Chin
    Leu, Shaw-Woei
    Chang, Che-Chia
    Lin, Chin-Kuo
    Lin, Chieh-Mo
    Fang, Yu -Hung
    Huang, Shu-Yi
    Lin, Yu -Ching
    Chuang, Min -Chun
    Yang, Tsung-Ming
    Hung, Ming-Szu
    Chou, Yen -Li
    Tsai, Ying-Huang
    Hsieh, Meng-Jer
    JOURNAL OF CRITICAL CARE, 2022, 72
  • [3] Bacterial co-infections and antimicrobial resistance associated with the Coronavirus Disease 2019 infection
    Teklemariam, Addisu D.
    Hashem, Anwar M.
    Saber, Saber H.
    Almuhayawi, Mohammed S.
    Haque, Shafiul
    Abujamel, Turki S.
    Harakeh, Steve
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2023, 39 (02) : 259 - 280
  • [4] Are omicron infections more frequently associated with bacterial co-infections?
    Teymurlu, Faig
    Sarsilmaz, Yasar Selim
    Guzel Aygoren, Ozge
    Gultekin, Beltinge
    Gul, Seymanur
    Suner, Asli
    Sayiner, Abdullah
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2024, 72 (02): : 131 - 136
  • [5] Metabolic Response to Tick-Borne Encephalitis Virus Infection and Bacterial Co-Infections
    Dobrzynska, Marta
    Moniuszko-Malinowska, Anna
    Jarocka-Karpowicz, Iwona
    Czupryna, Piotr
    Groth, Monika
    Skrzydlewska, Elzbieta
    PATHOGENS, 2022, 11 (04):
  • [6] Pulmonary and systemic bacterial co-infections in severe RSV bronchiolitis
    Duttweiler, L
    Nadal, D
    Frey, B
    ARCHIVES OF DISEASE IN CHILDHOOD, 2004, 89 (12) : 1155 - 1157
  • [7] Higher mortality of severe influenza patients with probable aspergillosis than those with and without other co-infections
    Yu, Wen-Liang
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S92 - S92
  • [8] Screening for co-infections in patients with substance use disorders and severe bacterial infections
    Varley, Cara D.
    Conte, Michael
    Streifel, Amber C.
    Winders, Bradie
    Sikka, Monica K.
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2022, 9
  • [9] Screening for co-infections in patients with substance use disorders and severe bacterial infections
    Varley, Cara D. D.
    Conte, Michael
    Streifel, Amber C. C.
    Winders, Bradie
    Sikka, Monica K. K.
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2022, 9
  • [10] Influenza and associated co-infections in critically ill immunosuppressed patients
    Martin-Loeches, Ignacio
    Lemiale, Virginie
    Geoghegan, Pierce
    McMahon, Mary Aisling
    Pickkers, Peter
    Soares, Marcio
    Perner, Anders
    Meyhoff, Tine Sylvest
    Bukan, Ramin Brandt
    Rello, Jordi
    Bauer, Philippe R.
    van de Louw, Andry
    Taccone, Fabio Silvio
    Salluh, Jorge
    Hemelaar, Pleun
    Schellongowski, Peter
    Rusinova, Katerina
    Terzi, Nicolas
    Mehta, Sangeeta
    Antonelli, Massimo
    Kouatchet, Achille
    Klepstad, Pal
    Valkonen, Miia
    Landburg, Precious Pearl
    Barratt-Due, Andreas
    Bruneel, Fabrice
    Pene, Frederic
    Metaxa, Victoria
    Moreau, Anne Sophie
    Souppart, Virginie
    Burghi, Gaston
    Girault, Christophe
    Silva, Ulysses V. A.
    Montini, Luca
    Barbier, Francois
    Nielsen, Lene B.
    Gaborit, Benjamin
    Mokart, Djamel
    Chevret, Sylvie
    Azoulay, Elie
    CRITICAL CARE, 2019, 23 (1):